Roy F Chemaly Selected Research

Cytomegalovirus Infections (Inclusion Disease)

9/2022	Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
10/2021	Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
1/2021	American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation.
1/2021	Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective.
10/2020	A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.
1/2020	Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients.
1/2020	Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant.
12/2019	Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management.
10/2018	Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients.
12/2016	How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy F Chemaly Research Topics

Disease

66	Infections 10/2022 - 09/2005
37	Neoplasms (Cancer) 06/2022 - 10/2005
15	Cytomegalovirus Infections (Inclusion Disease) 09/2022 - 06/2008
14	Respiratory Syncytial Virus Infections 12/2020 - 09/2007
13	Neutropenia 09/2022 - 01/2002
13	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2006
11	Virus Diseases (Viral Diseases) 01/2021 - 09/2006
11	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 09/2007
10	Pneumonia (Pneumonitis) 10/2022 - 09/2005
10	Human Influenza (Influenza) 04/2022 - 09/2006
9	COVID-19 01/2022 - 01/2020
7	Viremia 09/2022 - 12/2016
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 11/2007
6	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2015
6	Leukemia 07/2019 - 03/2006
6	Sepsis (Septicemia) 05/2019 - 08/2010
4	Bacteremia 12/2021 - 07/2009
4	Paramyxoviridae Infections (Parainfluenza) 01/2021 - 03/2012
4	Diarrhea 01/2019 - 09/2003
3	Lymphopenia (Lymphocytopenia) 12/2020 - 08/2013
3	Vomiting 12/2017 - 06/2008
3	Diabetes Mellitus 12/2016 - 12/2005
3	Mycoses (Diseases, Fungus) 01/2015 - 12/2005
2	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 04/2016
2	Lymphoma (Lymphomas) 03/2021 - 03/2006
2	Coinfection 01/2018 - 01/2012
2	Surgical Wound Infection 10/2017 - 02/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 01/2002
2	Clostridium Infections 02/2015 - 11/2014
2	Cross Infection (Nosocomial Infection) 09/2014 - 06/2007
2	Opportunistic Infections (Opportunistic Infection) 01/2012 - 11/2007
2	Nausea 07/2009 - 06/2008
2	Zygomycosis (Phycomycosis) 12/2005 - 01/2002
1	Disease Progression 01/2022
1	Breakthrough Infections 01/2022
1	Chickenpox 01/2021
1	Herpes Zoster 01/2021
1	Serum Sickness 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Reinfection 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020

Drug/Important Bio-Agent (IBA)

27	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2005
11	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 09/2007
10	letermovirIBA 07/2022 - 05/2014
7	Ganciclovir (Cytovene)FDA LinkGeneric 09/2022 - 06/2008
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 09/2005
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 09/2003
6	maribavirIBA 09/2022 - 06/2008
6	brincidofovirIBA 01/2020 - 10/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2008
4	Foscarnet FDA LinkGeneric 09/2022 - 01/2014
4	AntibodiesIBA 07/2021 - 01/2020
4	Pharmaceutical PreparationsIBA 01/2019 - 12/2005
4	VaccinesIBA 12/2018 - 01/2015
3	Valganciclovir FDA Link 09/2022 - 01/2015
3	Oseltamivir (Tamiflu)FDA Link 04/2022 - 01/2012
3	AntigensIBA 01/2021 - 04/2012
3	Acyclovir (Aciclovir)FDA LinkGeneric 01/2018 - 01/2009
3	SteroidsIBA 12/2016 - 01/2012
3	Cidofovir (Vistide)FDA Link 10/2016 - 03/2016
3	Neuraminidase (Sialidase)IBA 11/2014 - 04/2007
3	Vancomycin FDA LinkGeneric 01/2012 - 08/2010
3	Palivizumab FDA Link 03/2011 - 01/2009
2	Daptomycin FDA Link 12/2021 - 08/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 01/2021
2	oplunofuspIBA 01/2021 - 11/2014
2	Oxygen (Dioxygen)IBA 01/2021 - 12/2020
2	XenonIBA 01/2021 - 02/2015
2	presatovirIBA 12/2020 - 12/2020
2	EnzymesIBA 12/2020 - 06/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016 - 03/2011
2	Immunologic Factors (Immunomodulators)IBA 11/2014 - 01/2012
2	Zanamivir (Relenza)FDA Link 11/2014 - 01/2012
2	Rifampin (Rifampicin)FDA LinkGeneric 02/2011 - 12/2005
2	QuinolonesIBA 06/2010 - 06/2007
1	fibrin fragment D (D-dimer)IBA 06/2022
1	C-Reactive ProteinIBA 06/2022
1	baloxavirIBA 04/2022
1	EndonucleasesIBA 04/2022
1	COVID-19 VaccinesIBA 01/2022
1	varicella-zoster immune globulin (VZIG)IBA 01/2021
1	Aligeron (AS 2)IBA 01/2021
1	Viral ProteinsIBA 01/2021
1	CalcineurinIBA 01/2021
1	Peptides (Polypeptides)IBA 12/2020
1	Immunoglobulin G (IgG)IBA 04/2020
1	Immunoglobulin A (IgA)IBA 04/2020

Therapy/Procedure

53	Therapeutics 09/2022 - 09/2003
23	Cell Transplantation 10/2022 - 05/2014
18	Transplantation 07/2022 - 03/2006
10	Hematopoietic Stem Cell Transplantation 07/2019 - 10/2005
9	Drug Therapy (Chemotherapy) 09/2014 - 01/2002
6	Artificial Respiration (Mechanical Ventilation) 10/2022 - 01/2009
4	Stem Cell Transplantation 03/2021 - 09/2006
4	Catheters 08/2014 - 05/2002
3	Length of Stay 02/2017 - 01/2009
2	Hand Hygiene 01/2020 - 09/2010
2	Induction Chemotherapy 01/2019 - 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Organ Transplantation 06/2020